The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

Aug. 23, 2017
Applicants:

National University Corporation Nagoya University, Nagoya, JP;

Gifu University, Gifu, JP;

Gifu Prefecture, Gifu, JP;

Inventors:

Tokunori Yamamoto, Nagoya, JP;

Satoshi Suzuki, Nagoya, JP;

Yasuhito Funahashi, Nagoya, JP;

Yoshihisa Matsukawa, Nagoya, JP;

Momokazu Gotoh, Nagoya, JP;

Tomohiro Kitayama, Takayama, JP;

Yoichiro Hoshino, Funai-gun, JP;

Tetsuma Murase, Gifu, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 35/51 (2015.01); A61K 35/52 (2015.01); A61P 15/08 (2006.01); A61K 35/32 (2015.01); A61K 35/54 (2015.01); A61K 35/28 (2015.01); A61K 35/35 (2015.01); A61D 19/00 (2006.01); A61D 19/02 (2006.01); A61K 35/00 (2006.01); C12N 5/076 (2010.01); C12N 5/0775 (2010.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61D 19/00 (2013.01); A61D 19/02 (2013.01); A61K 35/00 (2013.01); A61K 35/28 (2013.01); A61K 35/32 (2013.01); A61K 35/35 (2013.01); A61K 35/51 (2013.01); A61K 35/52 (2013.01); A61K 35/54 (2013.01); A61P 15/08 (2018.01); C12N 5/061 (2013.01); C12N 5/0664 (2013.01); C12N 5/0665 (2013.01); C12N 5/0667 (2013.01); C12N 2500/80 (2013.01);
Abstract

It is an object to provide a technique useful for embryo transfer and development of reproductive medical care. Provided are a sperm activator containing a disrupted product of one or more cells selected from the group consisting of adipose tissue-derived stem cells, dental pulp-derived stem cells, bone marrow-derived stem cells, and umbilical cord blood-derived stem cells as an active ingredient, and an artificial insemination method utilizing the same.


Find Patent Forward Citations

Loading…